
|Articles|October 17, 2022
What's New on Dermatology Times®: October 17-21
Author(s)Kaitlyn Bader, Associate Editor
Click to see a preview of what to expect this week.
Advertisement
Some of the content the staff at Dermatology Times® will be publishing this week includes:
How pediatric nail disorders differ from adults and the examinations needed to rule out underlying diseases;
Adolescents with atopic dermatitis and how the changing seasons can affect itch;
Groundbreaking innovations in acne and rosacea;
How apremilast may be effective in treating recalcitrant cutaneous dermatomyositis;
Exclusive video interviews with KOLs at the Fall Clinical Dermatology Conference in Las Vegas, Nevada;
Plus more!
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis
2
FDA Accepts Bezuclastinib NDA for Advanced Systemic Mastocytosis
3
Genetic Study Links Higher BMI to Perceived Facial Aging, but Causality Remains Unproven
4
Defining AD Disease Flares vs Drug Effects: A Comparative Analysis of Phase 3 Systemic Therapy Trials
5






